Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

Highlights • COVID -19 cases are now confirmed in multiple countries.• Assessed the prevalence of comorbidities in infected patients.• Comorbidities are risk factors for severe compared with non-severe patients.• Help the health sector guide vulnerable populations and assess the risk of deterioration.

[1]  B. Hagberg,et al.  CLINICAL CHARACTERISTICS , 1972 .

[2]  C. Garlanda,et al.  Sexual Dimorphism in Innate Immunity , 2019, Clinical Reviews in Allergy & Immunology.

[3]  Wei Liu,et al.  Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province , 2020, Chinese medical journal.

[4]  Jing Yuan,et al.  Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury , 2020, Science China Life Sciences.

[5]  A. Chawla,et al.  Connecting type 1 and type 2 diabetes through innate immunity. , 2012, Cold Spring Harbor perspectives in medicine.

[6]  Mohammad A. Almazroa,et al.  Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Illness in Humans, Saudi Arabia, 2014 , 2016, Emerging infectious diseases.

[7]  Yahong Chen,et al.  [Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing]. , 2020, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.

[8]  Dong Wei,et al.  Clinical Features Predicting Mortality Risk in Patients With Viral Pneumonia: The MuLBSTA Score , 2019, Front. Microbiol..

[9]  M. Zhou,et al.  Burden of diabetes, hyperglycaemia in China from to 2016: Findings from the 1990 to 2016, global burden of disease study. , 2019, Diabetes & metabolism.

[10]  Hyo Youl Kim,et al.  Clinical courses and outcomes of hospitalized adult patients with seasonal influenza in Korea, 2011-2012: Hospital-based Influenza Morbidity & Mortality (HIMM) surveillance. , 2014, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[11]  China Cdc Weekly.  The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020 , 2020, China CDC weekly.

[12]  Z. Memish,et al.  The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China , 2020, International Journal of Infectious Diseases.

[13]  中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组.  The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China./ 新型冠状病毒肺炎流行病学特征分析 , 2020 .

[14]  Mark Loeb,et al.  Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis , 2013, BMJ.

[15]  M. Chin.  Populations at risk , 2005, Journal of General Internal Medicine.

[16]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[17]  E. Holmes,et al.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.

[18]  G. Burch.  [Cardiovascular diseases]. , 1956, Revista medica cubana.

[19]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[20]  M Q Zhang,et al.  [Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing]. , 2020, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.

[21]  S. Majumdar,et al.  Effectiveness of influenza vaccination in working-age adults with diabetes: a population-based cohort study , 2013, Thorax.

[22]  P. T. Ten Eyck,et al.  Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection , 2017, The Journal of Immunology.

[23]  C. Akdis,et al.  Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China , 2020, Allergy.

[24]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[25]  K. Dooley,et al.  Tuberculosis and diabetes mellitus: convergence of two epidemics. , 2009, The Lancet. Infectious diseases.

[26]  A. Badawi,et al.  Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis , 2016, International Journal of Infectious Diseases.